AAAAAA
Results:
1-22
|
Results: 22
Authors:
Jokiranta, TS
Westin, J
Nilsson, UR
Nilsson, B
Hellwage, J
Lofas, S
Gordon, DL
Ekdahl, KN
Meri, S
Citation: Ts. Jokiranta et al., Complement C3b interactions studied with surface plasmon resonance technique, INT IMMUNO, 1(3), 2001, pp. 495-506
Authors:
Gulbrandsen, N
Wisloff, F
Brinch, L
Carlson, K
Dahl, IM
Gimsing, P
Hippe, E
Hjorth, M
Knudsen, LM
Lamvik, J
Lenhoff, S
Lofvenberg, E
Nesthus, I
Nielsen, JL
Turesson, L
Westin, J
Citation: N. Gulbrandsen et al., Health-related quality of life in multiple myeloma patients receiving high-dose chemotherapy with autologous blood stem-cell support, MED ONCOL, 18(1), 2001, pp. 65-77
Authors:
Gulbrandsen, N
Wisloff, F
Nord, E
Lenhoff, S
Hjorth, M
Westin, J
Citation: N. Gulbrandsen et al., Cost-utility analysis of high-dose melphalan with autologous blood stem cell support vs. melphalan plus prednisone in patients younger than 60 years with multiple myeloma, EUR J HAEMA, 66(5), 2001, pp. 328-336
Authors:
Westin, J
Lindh, M
Nenonen, N
Lagging, LM
Norkrans, G
Wejstal, R
Citation: J. Westin et al., Monitoring virological responses to interferon-ribavirin and interferon monotherapy of chronic hepatitis C re-treated due to relapse or non-response, SC J IN DIS, 33(2), 2001, pp. 110-115
Authors:
Casassus, P
Gibson, J
Joshua, DE
Matthews, J
Diaz, JC
Gertz, MA
Kyle, R
Leong, T
Oken, MM
Fritz, E
Ludwig, H
Corrado, C
Lastiri, F
Peest, D
Grosbois, B
Vela-Ojeda, J
Avvisati, G
Mandelli, F
Petrucci, MT
Capnist, G
Child, JA
Drayson, MT
Dunn, J
MacLennan, I
Mellstedt, H
Osterborg, A
Rodjer, S
Turesson, I
Westin, J
Bergsagel, D
Browman, GP
Shustik, C
Zee, B
Hjorth, M
Holmberg, E
Rodjer, S
Turesson, I
Westin, J
Alison, R
Clarke, M
Elphinstone, P
Evans, V
Gray, R
Hicks, C
James, S
MacKinnon, L
Peto, R
Richards, S
Wheatley, K
Blade, J
Fontanillas, M
San Miguel, J
Aitchison, R
Newland, AC
Cunningham, D
Malpas, J
Powles, RL
Montuoro, A
Jacobson, J
Salmon, S
Citation: P. Casassus et al., Interferon as therapy for multiple myeloma: an individual patient data overview of 24 randomized trials and 4012 patients, BR J HAEM, 113(4), 2001, pp. 1020-1034
Authors:
Seidel, C
Hjertner, O
Abildgaard, N
Heickendorff, L
Hjorth, M
Westin, J
Nielsen, JL
Hjorth-Hansen, H
Waage, A
Sundan, A
Borset, M
Citation: C. Seidel et al., Serum osteoprotegerin levels are reduced in patients with multiple myelomawith lytic bone disease, BLOOD, 98(7), 2001, pp. 2269-2271
Authors:
Westin, J
Sundblad, LG
Strand, M
Hallgren, JE
Citation: J. Westin et al., Phenotypic differences between natural and selected populations of Picea abies. L. frost hardiness, SC J FOR R, 15(5), 2000, pp. 489-499
Authors:
Westin, J
Sundblad, LG
Strand, M
Hallgren, JE
Citation: J. Westin et al., Phenotypic differences between natural and selected populations of Picea abies. II. Apical mitotic activity and growth related parameters, SC J FOR R, 15(5), 2000, pp. 500-509
Authors:
Hannerz, M
Westin, J
Citation: M. Hannerz et J. Westin, Growth cessation and autumn-frost hardiness in one-year-old Picea abies progenies from seed orchards and natural stands, SC J FOR R, 15(3), 2000, pp. 309-317
Authors:
Lenhoff, S
Hjorth, M
Holmberg, E
Turesson, I
Westin, J
Nielsen, JL
Wisloff, F
Brinch, L
Carlson, K
Carlson, M
Dahl, IM
Gimsing, P
Hippe, E
Johnsen, H
Lamvik, J
Lofvenberg, E
Nesthus, I
Rodjer, S
Citation: S. Lenhoff et al., Impact on survival of high-dose therapy with autologous stem cell support in patients younger than 60 years with newly diagnosed multiple myeloma: a population-based study, BLOOD, 95(1), 2000, pp. 7-11
Authors:
Westin, J
Sneden, C
Gustafsson, B
Cowan, JJ
Citation: J. Westin et al., The r-process-enriched low-metallicity giant HD 115444, ASTROPHYS J, 530(2), 2000, pp. 783-799
Authors:
Silverin, B
Fange, R
Viebke, PA
Westin, J
Citation: B. Silverin et al., Seasonal changes in mass and histology of the spleen in Willow Tits Parus montanus, J AVIAN BIO, 30(3), 1999, pp. 255-262
Authors:
Carlson, K
Larsson, A
Simonsson, B
Turesson, I
Westin, J
Ljunghall, S
Citation: K. Carlson et al., Evaluation of bone disease in multiple myeloma: a comparison between the resorption markers urinary deoxypyridinoline creatinine (DPD) and serum ICTP, and an evaluation of the DPD osteocalcin and ICTP osteocalcin ratios, EUR J HAEMA, 62(5), 1999, pp. 300-306
Authors:
Hjorth, M
Holmberg, E
Rodjer, S
Turesson, I
Westin, J
Wisloff, F
Citation: M. Hjorth et al., Survival in conventionally treated younger (< 60 years) multiple myeloma patients: no improvement during two decades, EUR J HAEMA, 62(4), 1999, pp. 271-277
Authors:
Westin, J
Citation: J. Westin, Conventional chemotherapy in multiple myeloma, PATH BIOL, 47(2), 1999, pp. 169-171
Authors:
Westin, J
Lagging, LM
Wejstal, R
Norkrans, G
Dhillon, AP
Citation: J. Westin et al., Interobserver study of liver histopathology using the Ishak score in patients with chronic hepatitis C virus infection, LIVER, 19(3), 1999, pp. 183-187
Authors:
Westin, J
Sundblad, LG
Strand, M
Hallgren, JE
Citation: J. Westin et al., Apical mitotic activity and growth in clones of Norway spruce in relation to cold hardiness, CAN J FORES, 29(1), 1999, pp. 40-46
Chronic hepatitis C in Sweden: Genotype distribution over time in different epidemiological settings
Authors:
Westin, J
Lindh, M
Lagging, LM
Norkrans, G
Wejstal, R
Citation: J. Westin et al., Chronic hepatitis C in Sweden: Genotype distribution over time in different epidemiological settings, SC J IN DIS, 31(4), 1999, pp. 355-358
Authors:
Turesson, I
Abildgaard, N
Ahlgren, T
Dahl, IM
Holmberg, E
Hjorth, M
Nielsen, JL
Oden, A
Seidel, C
Waage, A
Westin, J
Wisloff, F
Citation: I. Turesson et al., Prognostic evaluation in multiple myeloma: an analysis of the impact of new prognostic factors, BR J HAEM, 106(4), 1999, pp. 1005-1012
Authors:
Thunberg, U
Banghagen, M
Bengtsson, M
Christensen, LD
Geisler, CH
Lenhoff, S
Mortensen, BT
Olofsson, T
Simonsson, B
Andersen, NS
Sundstrom, C
Swedin, A
Sallstrom, JF
Thuresson, B
Westin, J
Carlson, K
Citation: U. Thunberg et al., Linear reduction of clonal cells in stem cell enriched grafts in transplanted multiple myeloma, BR J HAEM, 104(3), 1999, pp. 546-552
Authors:
Pasquali, S
Maqueo, JD
Vela, J
Kyle, RA
Leong, T
Fritz, E
Suciu, S
Palva, IP
Oivanen, T
Corrado, C
Lastiri, FJ
Peest, D
Kildahl-Andersen, O
Maniatis, A
Alison, R
Clarke, M
Evans, V
Gray, R
Greaves, E
Hall, E
Hicks, C
James, S
Peto, R
Richards, S
Sinclair, D
Tooth, A
Wheatley, K
Avvisati, G
Boccadoro, M
Bugliosi, R
Mandelli, F
Petrucci, MT
Pileri, A
Tribalto, M
Alexanian, R
Delasalle, KB
Child, J
Dunn, J
MacLennan, I
Milligan, D
Mellstedt, H
Osterborg, A
Hjorth, M
Holmberg, E
Rodjer, S
Westin, J
Kamiya, O
Shimizu, K
Bergsagel, DE
Shustik, C
Hippe, E
Kjaersgaard, E
Turesson, I
Westin, J
Riccardi, A
Ucci, G
Blade, J
Fontanillas, M
De Rosa, L
Montuoro, A
Bartolucci, AA
Omura, GA
Stagg, M
Salmon, S
Tangen, C
Jacobs, P
Wood, L
Levy, LM
Citation: S. Pasquali et al., Combination chemotherapy versus melphalan plus prednisone as treatment formultiple myeloma: An overview of 6,633 patients from 27 randomized trials, J CL ONCOL, 16(12), 1998, pp. 3832-3842
Authors:
Swedin, A
Lenhoff, S
Olofsson, T
Thuresson, B
Westin, J
Citation: A. Swedin et al., Clinical utility of immunoglobulin heavy chain gene rearrangement identification for tumour cell detection in multiple myeloma, BR J HAEM, 103(4), 1998, pp. 1145-1151
Risultati:
1-22
|